Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial. [electronic resource]
Producer: 20150825Description: 559-67 p. digitalISSN:- 1873-2518
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Animals
- Antibodies, Neutralizing -- blood
- Antibodies, Viral -- blood
- Drug Combinations
- Female
- Hemagglutination Inhibition Tests
- Humans
- Immunization, Secondary -- methods
- Indonesia
- Influenza A Virus, H5N1 Subtype -- immunology
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- prevention & control
- Leukocytes, Mononuclear -- immunology
- Male
- Middle Aged
- Neutralization Tests
- Placebos -- administration & dosage
- Polysorbates -- administration & dosage
- Single-Blind Method
- Squalene -- administration & dosage
- Turkey
- Young Adult
- alpha-Tocopherol -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.